CVP, CFO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Scott B. Ullem (insider trades) sold 33,150 shares of EW on 09/28/2020 at an average price of $78.11 a share. The total sale was $2.6 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $48.32 billion; its shares were traded at around $77.71 with a P/E ratio of 66.83 and P/S ratio of 11.37. Edwards Lifesciences Corp had annual average EBITDA growth of 16.30% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CFO Recent Trades:
- CVP, CFO Scott B. Ullem sold 33,150 shares of EW stock on 09/28/2020 at the average price of $78.11. The price of the stock has decreased by 0.51% since.
- CVP, CFO Scott B. Ullem sold 33,150 shares of EW stock on 09/15/2020 at the average price of $83.43. The price of the stock has decreased by 6.86% since.
- CVP, CFO Scott B. Ullem sold 26,700 shares of EW stock on 09/14/2020 at the average price of $82.21. The price of the stock has decreased by 5.47% since.
Directors and Officers Recent Trades:
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 13,074 shares of EW stock on 09/11/2020 at the average price of $82.45. The price of the stock has decreased by 5.75% since.
- CVP, Japan & Intercontinental Huimin Wang sold 11,730 shares of EW stock on 09/11/2020 at the average price of $82.44. The price of the stock has decreased by 5.74% since.
- CVP, TAVR Larry L Wood sold 10,698 shares of EW stock on 09/01/2020 at the average price of $85.09. The price of the stock has decreased by 8.67% since.
For the complete insider trading history of EW, click here
.This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
